Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RACELINES: Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetES

NCT03433248 is registered in ClinicalTrials.gov with M.H.H. Kramer as lead sponsor.

NCT NCT03433248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03433248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RACELINES: Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetES
Lead sponsor
M.H.H. Kramer
Phase
Phase 4
Overall status
Unknown status
Start date
November 9, 2017
Completion date
September 1, 2022
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type2 diabetes